Expanding 177Lutetium-PSMA-617 Use in the CommunityByMatthew Kurian, MD,Olsi Gjyshi, MD,Jason RaweMay 12th 2024Training at a major academic center offers firsthand exposure to groundbreaking 177Lu-PSMA-617 treatment for advanced prostate cancer.